Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
12/29/1999 | EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof |
12/29/1999 | EP0379483B1 1,2,3,4,10,14b-HEXAHYDRODIBENZO c,f]PYRAZINO- 1,2-a]AZEPINO DERIVATIVES |
12/29/1999 | CN1239998A Lactobacillus bifidus growth promoting composition and use thereof |
12/29/1999 | CN1239962A 1,4-diazabicyclo [2,2,2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |
12/29/1999 | CN1239959A Subsitutted 2(2,6-dioxopiperidin-3-yl) phthalimides and -1-xoisoindolines and method of reducing TNF-alpha levels |
12/29/1999 | CN1239952A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
12/29/1999 | CN1239941A Aryl or heteroaryl substd. 3, 4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo [1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs. |
12/29/1999 | CN1239894A Inositol polyphosphate derivatives and method of using same |
12/29/1999 | CN1239887A Pharmaceutical compositions containing N-sulphonyl indolin derivatives |
12/29/1999 | CN1239718A 11-acetyl-12,13-dioxa bicyclo [8.2.1] tridecenone -derivative, its preparation and medicine containing the compound |
12/29/1999 | CN1047775C N-piperidino 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl pyrazole-3-formyl amide, its preparation and drug composition |
12/29/1999 | CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion |
12/29/1999 | CA2335876A1 Protease inhibitors |
12/29/1999 | CA2335858A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
12/29/1999 | CA2330175A1 Ependymal neural stem cells and method for their isolation |
12/28/1999 | US6008357 1 -azabicyclo(2.2.2)octan-3-amine, (2-diphenylmethyl)-n-((2-methoxy-5-(1-methylethyl)phenyl)methy l) is reacted with 1r-(-)-10-camphorsulfonic acid to obtain camphorsulfonic acid salt |
12/28/1999 | US6008245 Treatment of prophylaxis and cardiovascular disorders, in particular arrhythmias, for the treatment of ulcers of the gastrointestinal disorders, diarrheal diseases |
12/28/1999 | US6008243 An enzyme inhibitor for preventing the degradation and remodeling of connective tissues |
12/28/1999 | US6008220 A gelatinase a inhibitor for treating multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer |
12/28/1999 | US6008017 Human cardiac/brain tolloid-like protein |
12/28/1999 | US6007821 Immunosuppression; organ transplants, insulin dependent diabetes |
12/28/1999 | US6007808 Nutrient mixture of eubiotic bacteria and glutamine or glutamine-containing polypeptide |
12/28/1999 | US6007805 Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver |
12/23/1999 | WO1999066048A1 A mutant human hepatitis b viral strain and uses thereof |
12/23/1999 | WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof |
12/23/1999 | WO1999065942A1 Cyclic somatostatin analogs |
12/23/1999 | WO1999065940A1 Anti-angiogenic proteins and methods of use thereof |
12/23/1999 | WO1999065917A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
12/23/1999 | WO1999065909A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
12/23/1999 | WO1999065908A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
12/23/1999 | WO1999065898A1 Imidazolyl derivatives |
12/23/1999 | WO1999065895A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
12/23/1999 | WO1999065887A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
12/23/1999 | WO1999065884A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
12/23/1999 | WO1999065880A1 Aryl alkanoylpyridazines |
12/23/1999 | WO1999065877A1 Therapeutic biaryl derivatives |
12/23/1999 | WO1999065876A1 Aryl substituted olefinic amines and their use as cholinergic receptors agonists |
12/23/1999 | WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
12/23/1999 | WO1999065571A2 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
12/23/1999 | WO1999065514A1 Protease containing hairball remedy and use thereof |
12/23/1999 | WO1999065513A2 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders |
12/23/1999 | WO1999065495A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
12/23/1999 | WO1999065492A1 Inhibition of serotonin reuptake |
12/23/1999 | WO1999065488A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
12/23/1999 | WO1999065486A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
12/23/1999 | WO1999065478A1 Therapeutic compositions and methods of use |
12/23/1999 | WO1999065449A2 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
12/23/1999 | WO1999065310A1 Il-8 receptor antagonists |
12/23/1999 | WO1998054171A8 Novel form of s-omeprazole |
12/23/1999 | WO1996002535A8 Process for synthesis of substituted sulphoxides |
12/23/1999 | DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine |
12/23/1999 | CA2709735A1 Aryl substituted olefinic amines and their use as cholinergic receptors agonists |
12/23/1999 | CA2677519A1 Aryl substituted olefinic amines and their use as cholinergic receptors agonists |
12/23/1999 | CA2335724A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
12/23/1999 | CA2335435A1 Imidazolyl derivatives |
12/23/1999 | CA2335336A1 Inhibition of serotonin reuptake |
12/23/1999 | CA2335294A1 Inhibitors of transcription factor nf-.kappa.b |
12/23/1999 | CA2335293A1 Inhibitors of transcription factor nf-.kappa.b |
12/23/1999 | CA2335292A1 Il-8 receptor antagonists |
12/23/1999 | CA2335184A1 Cyclic somatostatin analogs |
12/23/1999 | CA2335134A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
12/23/1999 | CA2335112A1 Therapeutic combinations for musculoskeletal frailty |
12/23/1999 | CA2334254A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
12/23/1999 | CA2333666A1 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
12/23/1999 | CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
12/23/1999 | CA2332325A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
12/23/1999 | CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof |
12/23/1999 | CA2331834A1 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders |
12/23/1999 | CA2331332A1 Anti-angiogenic proteins and methods of use thereof |
12/22/1999 | EP0965351A2 Pharmaceutical composition for treating side-effects of a diet with reduced amount of carbohydrates |
12/22/1999 | EP0965345A2 Use of acemannan |
12/22/1999 | EP0965344A1 Prophylactic and therapeutic agent for inflammatory intestinal diseases |
12/22/1999 | EP0965342A1 Preparation for percutaneous administration |
12/22/1999 | EP0965278A1 Dietetic food composition and dietetic method using such composition |
12/22/1999 | EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
12/22/1999 | EP0964859A1 New process |
12/22/1999 | EP0964849A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
12/22/1999 | EP0964687A1 Pharmaceutical compositions with antimicrobial activity |
12/22/1999 | EP0674628B1 Chemopreventive compounds and a preparation method and use thereof |
12/22/1999 | EP0635018B1 4-(1H-2-METHYLIMIDAZO[4,5-c]PYRIDINYLMETHYL)PHENYLSULPHONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF |
12/22/1999 | EP0609394B1 Anti-explosion pads and their method of use |
12/22/1999 | CN1239510A Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4) |
12/22/1999 | CN1238989A Medicine for curing infantile malnutrition and its preparing process |
12/22/1999 | CN1238987A Chinese medicine for treating digestive tract inflammation and ulcer |
12/22/1999 | CN1238985A Exterior-applied medicine for treating cold symptoms type gastroenteropathy and its preparing process |
12/22/1999 | CN1238982A Chinese patent medicine for treating gastrosis |
12/22/1999 | CN1238946A Liquid spray for treating oral and throat diseases and its preparing process |
12/21/1999 | US6004556 Staphylococcus aureus RSBU-1 |
12/21/1999 | US6004552 Administration of a monoclonal antibody capable of binding to a human cd40 antigen located on the surface of a human b cell, wherein the binding of the antibody to the cd40 antigen prevents the growth or differentiation of the b cell |
12/21/1999 | CA2197075C Method of gene therapy using dna vectors without selection marker gene |
12/21/1999 | CA2060624C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
12/16/1999 | WO1999064615A1 Formulations for electroporation |
12/16/1999 | WO1999064436A1 Cloning and identification of the motilin receptor |
12/16/1999 | WO1999064426A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors |
12/16/1999 | WO1999064423A1 Furopyridine derivatives and their therapeutical use |
12/16/1999 | WO1999064420A1 β-CARBOLINE COMPOUNDS |
12/16/1999 | WO1999064415A1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
12/16/1999 | WO1999064410A1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE |
12/16/1999 | WO1999064409A2 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
12/16/1999 | WO1999064403A1 1,5-benzodiazepine derivatives |